Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus.
Dickerson, Faith B; Stallings, Cassie R; Boronow, John J; Origoni, Andrea E; Sullens, Anne; Yolken, Robert H.
; 107(2-3): 147-9, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19008077
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients.
Interventions for men and women with their first episode of genital herpes.
Antiviral agents for infectious mononucleosis (glandular fever).
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.
In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir.
A position statement on the management of patients with pityriasis rosea.
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.
Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.